Retour
Fourchette du Jour
29,77 €
41,00 €
Fourchette 52 Semaines
6,71 €
53,65 €
Volume
7 832 474
Moyenne 50J / 200J
45,69 €
/
29,72 €
Clôture Précédente
49,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -11,6 | 0,2 |
| P/B | 4,3 | 3,0 |
| ROE % | -47,5 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,7 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
53,83 €
+69.7%
Low: 46,00 €
High: 68,00 €
BPA Prévisionnel
-3,14 €
CA Est.
1,33M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
-3,98 €
-3,98 € – -3,98 €
|
69,22M | 2 |
| FY2028 |
-3,88 €
-6,03 € – -2,56 €
|
36,82M | 4 |
| FY2027 |
-3,53 €
-5,39 € – -2,61 €
|
3,64M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-25 | -0,76 € | -0,80 € | -6,4% |
| 2025-11-06 | -0,74 € | -0,66 € | +10,8% |
| 2025-08-12 | -0,79 € | -0,77 € | +2,5% |
| 2025-05-14 | -0,76 € | -1,15 € | -51,3% |
| 2025-03-31 | 0,45 € | -18,32 € | -4171,1% |
| 2024-09-30 | N/A | -0,57 € | — |
| 2024-06-30 | N/A | 3,18 € | — |
| 2024-03-31 | N/A | -0,74 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Earnings declined -351,04% over the past year
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -112,73M
PEG of 0,00 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)-351,04%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-47,52%
ROIC-28,33%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,07
Current Ratio15,50
Interest Coverage0,00
Valorisation
P/E Ratio
-11,64
Forward P/EN/A
P/B Ratio4,30
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -351,04% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -131,12M |
| ROE | -47,52% | ROA | -33,02% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -112,73M |
| ROIC | -28,33% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 15,50 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -11,64 | Forward P/E | N/A |
| P/B Ratio | 4,30 | P/S Ratio | N/A |
| PEG Ratio | 0,00 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 1295,55 |
| Forward P/S | 1145,12 | Fwd Earnings Yield | N/A |
| FCF Yield | -7,38% | ||
| Market Cap | 1,53B | Enterprise Value | 1,36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0,0 | 167,50M | 0,0 | 0,0 |
| Net Income | -131,12M | 52,23M | -100,42M | -114,94M |
| EPS (Diluted) | -3,05 | 0,08 | -2,29 | -2,63 |
| Gross Profit | 0,0 | 167,50M | 0,0 | 0,0 |
| Operating Income | -142,90M | 57,59M | -98,55M | -111,03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 397,13M | 240,54M | 71,50M | 149,96M |
| Total Liabilities | 42,16M | 43,64M | 61,45M | 48,51M |
| Shareholders' Equity | 354,97M | 196,90M | 10,05M | 101,44M |
| Total Debt | 23,31M | 26,63M | 49,62M | 32,06M |
| Cash & Equivalents | 189,25M | 196,81M | 29,16M | 99,92M |
| Current Assets | 349,72M | 201,67M | 34,11M | 106,15M |
| Current Liabilities | 22,56M | 20,67M | 16,32M | 20,78M |